Reproducibility of 18F-FDG and 3′-Deoxy-3′-18F-Fluorothymidine PET Tumor Volume Measurements
Open Access
- 18 August 2010
- journal article
- research article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 51 (9) , 1368-1376
- https://doi.org/10.2967/jnumed.110.078501
Abstract
The objective of this study was to establish the repeatability and reproducibility limits of several volume-related PET image–derived indices—namely tumor volume (TV), mean standardized uptake value, total glycolytic volume (TGV), and total proliferative volume (TPV)—relative to those of maximum standardized uptake value (SUVmax), commonly used in clinical practice. Methods: Fixed and adaptive thresholding, fuzzy C-means, and fuzzy locally adaptive Bayesian methodology were considered for TV delineation. Double-baseline 18F-FDG (17 lesions, 14 esophageal cancer patients) and 3′-deoxy-3′-18F-fluorothymidine (18F-FLT) (12 lesions, 9 breast cancer patients) PET scans, acquired at a mean interval of 4 d and before any treatment, were used for reproducibility evaluation. The repeatability of each method was evaluated for the same datasets and compared with manual delineation. Results: A negligible variability of less than 5% was measured for all segmentation approaches in comparison to manual delineation (5%–35%). SUVmax reproducibility levels were similar to others previously reported, with a mean percentage difference of 1.8% ± 16.7% and −0.9% ± 14.9% for the 18F-FDG and 18F-FLT lesions, respectively. The best TV, TGV, and TPV reproducibility limits ranged from −21% to 31% and −30% to 37% for 18F-FDG and 18F-FLT images, respectively, whereas the worst reproducibility limits ranged from −90% to 73% and −68% to 52%, respectively. Conclusion: The reproducibility of estimating TV, mean standardized uptake value, and derived TGV and TPV was found to vary among segmentation algorithms. Some differences between 18F-FDG and 18F-FLT scans were observed, mainly because of differences in overall image quality. The smaller reproducibility limits for volume-derived image indices were similar to those for SUVmax, suggesting that the use of appropriate delineation tools should allow the determination of tumor functional volumes in PET images in a repeatable and reproducible fashion.Keywords
This publication has 24 references indexed in Scilit:
- Doctor, what does my future hold? The prognostic value of FDG-PET in solid tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapyActa Oncologica, 2010
- Prognostic Value of Metabolic Tumor Volume Measured by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients with Esophageal CarcinomaAnnals of Surgical Oncology, 2009
- Metabolic Tumor Volume of [18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Predicts Short-Term Outcome to Radiotherapy With or Without Chemotherapy in Pharyngeal CancerClinical Cancer Research, 2009
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid TumorsJournal of Nuclear Medicine, 2009
- Early Prediction of Response to Chemotherapy and Survival in Malignant Pleural Mesothelioma Using a Novel Semiautomated 3-Dimensional Volume-Based Analysis of Serial 18F-FDG PET ScansJournal of Nuclear Medicine, 2007
- Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug DevelopmentClinical Cancer Research, 2005
- Effects of ROI definition and reconstruction method on quantitative outcome and applicability in a response monitoring trialEuropean Journal of Nuclear Medicine and Molecular Imaging, 2004
- Influence of OSEM and segmented attenuation correction in the calculation of standardised uptake values for [18F]FDG PETEuropean Journal of Nuclear Medicine and Molecular Imaging, 2001
- Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging The Visual Response Score and the Change in Total Lesion GlycolysisClinical Positron Imaging, 1999